Ex-Medtronic CEO Bill Hawkins joins Ketryx board

Retired Medtronic Chair and CEO Bill Hawkins has joined the Ketryx board, the medtech regulatory software developer will announce today.

“Every life sciences CEO I speak to is trying to understand how to use AI to accelerate safe innovation,” Hawkins said in a statement shared with Medical Design & Outsourcingahead of the announcement. “Companies want AI throughout development, in compliance workflows, and increasingly inside the products themselves, but most don’t have the infrastructure needed to use it safely, and at scale, in a regulated environment. This is one of the most important problems to solve, and it’s the reason I’ve decided to join Ketryx’s board.”

He later continued, “Technology evolution has brought forward AI that is enabling companies to accelerate the development of new products critical for improving the human condition. What impressed me about Ketryx was how they envisioned using AI to build safer products faster. That change will unlock the next decade of medicine, and it runs on infrastructure that didn’t exist until now.”